• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

FDA Rejects Lilly’s Eczema Treatment Over Third-Party Manufacturing Issues

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Oct 02, 2023 at 10:42: AM
via The FDA has rejected Eli Lilly’s investigational antibody lebrikizumab for the treatment of moderate-to-severe atopic dermatitis due to manufacturing problems, the company announced on Monday.

article source
 

<



Similar threads

cafead
Eli Lilly says U.S. FDA rejects accelerated approval for Alzheimer&#039;s drug
Replies
0
Views
262
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
In Expected Decision, FDA Rejects Lilly&#039;s Sintilimab in NSCLC
Replies
0
Views
124
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA Rejects Rocket’s Gene Therapy, Cites Need for Additional CMC Info
Replies
0
Views
49
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA Rejects Aldeyra’s Dry Eye Drug, Cites Need for Additional Trial
Replies
0
Views
220
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA Rejects Alvotech’s Stelara Biosimilar as Manufacturing Problems Continue
Replies
0
Views
175
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote